Biobank: ATBC Study (Finland): Difference between revisions
m (Update categories.) |
m (Update categories.) |
||
| Line 143: | Line 143: | ||
<span style="display:none">hasDataAccessInstructions::[https://thl.fi/en/research-and-development/thl-biobank/for-researchers/application-process click here to access</span> | <span style="display:none">hasDataAccessInstructions::[https://thl.fi/en/research-and-development/thl-biobank/for-researchers/application-process click here to access</span> | ||
<span style="display:none">isDatabase</span> | <span style="display:none">isDatabase</span> | ||
<span style="display:none">hasCancerType::C00-C97: All cancer types</span> | |||
<span style="display:none">hasCancerType::C00-C14: Mouth/throat cancers</span> | |||
<span style="display:none">hasCancerType::C15-C26: Digestive system cancers</span> | |||
<span style="display:none">hasCancerType::C30-C39: Lung/chest cancers</span> | |||
<span style="display:none">hasCancerType::C40-C41: Bone cancers</span> | |||
<span style="display:none">hasCancerType::C43-C44: Skin cancers/melanoma</span> | |||
<span style="display:none">hasCancerType::C45-C49: Soft tissue cancer</span> | |||
<span style="display:none">hasCancerType::C50: Breast cancer</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancers</span> | |||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | |||
<span style="display:none">hasCancerType::C64-C68: Urinary system cancers</span> | |||
<span style="display:none">hasCancerType::C69-C72: Eye and brain cancer</span> | |||
<span style="display:none">hasCancerType::C73-C75: Thyroid and other gland cancers</span> | |||
<span style="display:none">hasCancerType::C76-C80: Cancers of unknown or unspecified areas</span> | |||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | |||
<span style="display:none">hasCancerType::C97-C97: Cancers in multiple locations from the start</span> | |||
<span style="display:none">hasCancerType::D00-D09: Early-stage cancers not yet spread</span> | |||
<span style="display:none">hasCancerType::D10-D36: Benign tumour</span> | |||
<span style="display:none">hasCancerType::D37-D48: Growths of uncertain nature</span> | |||
<span style="display:none">hasCancerType::unknown</span> | |||
Revision as of 11:14, 6 December 2025
Go back to Finland page
Type of database: clinical trial database; research study; registry; pharmacovigilance; biobank.
Primary purpose: Store the sample collection and data information of participants from the study "The alpha-tocopherol, beta-carotene lung cancer prevention study", which was a randomized, double-blinded, placebo-controlled trial testing whether alpha-tocopherol and/or beta-carotene supplements can reduce the incidence of lung cancer and other cancers.
Sponsor, manager or home institution: THL Biobank.
Type of information: longitudinal. region; year; age; number of visits; place of residence; education; marital status; periodicity of physician consultation; check-up examinations; diagnosis; smoking habit; medical procedures; employment status; medication use; screening.
Data level: patient level.
Number of records: About 29,000 sample donors.
Date range: 1985 - 1993
Cancer areas of interest: C00-D48: All neoplasms. Click here to learn more.
Data access: not publicly available. Click here to access. Data has access costs. Data requires a grant proposal to be accessed. Instructions to request data for restricted content click here to access.
Contact information: Click here to access.